Organic Chemistry Research Laboratory, School of Chemical Sciences, Solapur University, Solapur 413 255, India.
Bioorg Med Chem. 2010 Feb;18(3):1364-70. doi: 10.1016/j.bmc.2009.11.066. Epub 2009 Dec 6.
Chalcones have been identified as interesting compounds with cytotoxicity, anti-inflammatory and antioxidant properties. In the present study, simple methoxychalcones were synthesized by Claisen-Schmidt condensation reaction and evaluated for above biological activities. The structures of the compounds were established by IR, (1)H NMR and mass spectral analysis. The data revealed that compound 3s (99-100% at 10 microM concentration) completely inhibit the selected five human cancer cell lines as compared to standard flavopiridol and gemcitabine (70-90% at 700 nM and 500 nM concentrations, respectively), followed by 3a, 3n,3o,3p,3q,3r. Among the tested compounds 3l, 3m, 3r, and 3s exhibited promising anti-inflammatory activity against TNF-alpha and IL-6 with 90-100% inhibition at 10 microM concentration. DPPH free radical scavenging activity was given by the compounds 3o, 3n, 3l, 3r, 3m, 3a, 3p, 3c and 3s at 1mM concentration. Overall, 3s was obtained as lead compound with promising anticancer, anti-inflammatory and antioxidant activities. Bioavailability of compounds were checked by in vitro cytotoxicity study and confirmed to be nontoxic. The structure activity relationship (SAR) and in silico drug relevant properties (HBDs, HBAs, PSA, cLogP, ionization potential, molecular weight, E(HOMO) and E(LUMO)) further confirmed that the compounds were potential candidates for future drug discovery study.
查耳酮被认为是具有细胞毒性、抗炎和抗氧化特性的有趣化合物。在本研究中,通过 Claisen-Schmidt 缩合反应合成了简单的甲氧基查耳酮,并对其上述生物活性进行了评价。通过红外光谱(IR)、(1)H NMR 和质谱分析确定了化合物的结构。数据表明,与标准 flavopiridol 和 gemcitabine(浓度分别为 700 nM 和 500 nM 时的 70-90%)相比,化合物 3s(在 10 microM 浓度下完全抑制所选的五种人类癌细胞系,达到 99-100%),其次是 3a、3n、3o、3p、3q、3r。在所测试的化合物中,3l、3m、3r 和 3s 对 TNF-alpha 和 IL-6 表现出有希望的抗炎活性,在 10 microM 浓度下抑制率达到 90-100%。化合物 3o、3n、3l、3r、3m、3a、3p、3c 和 3s 在 1mM 浓度下表现出 DPPH 自由基清除活性。总体而言,3s 是一种具有潜在抗癌、抗炎和抗氧化活性的先导化合物。通过体外细胞毒性研究检查了化合物的生物利用度,并证实其无毒性。结构活性关系(SAR)和计算药物相关性质(HBDs、HBAs、PSA、cLogP、电离势、分子量、E(HOMO)和 E(LUMO))进一步证实,这些化合物是未来药物发现研究的潜在候选物。